Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penehyclidine Hydrochloride for Microcirculatory Dysfunction in Pediatric Shock
NCT07519226Completed
- Start
- May 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of penehyclidine in Shock (2 arms). Primary endpoint: Duration of Capillary Refill Time at 7 days. Started May 2024; status: completed.
02
Drugs
penehyclidine
03
Conditions
Shock
Beyond the preview
Go deeper on NCT07519226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519226.